» Authors » Antonio Cisternino

Antonio Cisternino

Explore the profile of Antonio Cisternino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 116
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mormone E, Cisternino A, Capone L, Caradonna E, Sbarbati A
Int J Mol Sci . 2024 Feb; 25(4). PMID: 38397003
Given the recent evidence in the clinical application of regenerative medicine, mostly on integumentary systems, we focused our interests on recent bladder regeneration approaches based on mesenchymal stem cells (MSCs),...
2.
Cisternino A, Capone L, Rosati A, Latiano C, Sebastio N, Colella A, et al.
Arch Ital Urol Androl . 2023 May; 95(2):11058. PMID: 37212881
Introduction And Objectives: The aim of the study was to evaluate genital sparing radical cystectomy surgery in female patients from the point of view of both oncologic and functional outcomes...
3.
Maiorano B, De Giorgi U, Ciardiello D, Schinzari G, Cisternino A, Tortora G, et al.
Biomedicines . 2022 Feb; 10(2). PMID: 35203620
Background: In advanced bladder cancer (BCa), platinum-based chemotherapy represents the first-choice treatment. In the last ten years, immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape of many solid tumors....
4.
Maiorano B, Schinzari G, Ciardiello D, Rodriquenz M, Cisternino A, Tortora G, et al.
Vaccines (Basel) . 2021 Jul; 9(6). PMID: 34207536
Background: In the last years, many new treatment options have widened the therapeutic scenario of genitourinary malignancies. Immunotherapy has shown efficacy, especially in the urothelial and renal cell carcinomas, with...
5.
Piazzolla A, Paroni G, Bazzocchi F, Cassese M, Cisternino A, Ciuffreda L, et al.
Pathogens . 2021 Jul; 10(6). PMID: 34205096
Background And Aims: The WHO has solicited all countries to eliminate HCV by 2030. The Italian government started routine screening for HCV infection in January 2021, initially targeting subjects born...
6.
Granelli P, Campobasso D, Salsi P, Creti G, Moretti M, Cisternino A, et al.
Urologia . 2013 Jan; 80 Suppl 22:11-5. PMID: 23341199
Background: The endourological technique is a safe and effective approach in the treatment of large stones in the pediatric population with congenital malformations. Introduction: The VACTERL association is a group...
7.
Prayer-Galetti T, Sacco E, Pagano F, Gardiman M, Cisternino A, Betto G, et al.
BJU Int . 2007 Mar; 100(2):274-80. PMID: 17355369
Objective: To assess the feasibility and activity of a neoadjuvant treatment combining a luteinizing hormone-releasing hormone (LHRH)-analogue, estramustine and docetaxel before radical retropubic prostatectomy (RRP) in patients with high-risk prostate...
8.
Titta M, Tavolini I, Dal Moro F, Cisternino A, Bassi P
J Sex Med . 2006 Feb; 3(2):267-73. PMID: 16490019
Aim: The efficacy of prostaglandin E1 (PGE1)-intracavernous injection (ICI) therapy for erectile dysfunction (ED) after non-nerve-sparing (NNS) radical pelvic surgery depends on patient compliance. The purpose of this study was...
9.
Ficarra V, Zattoni F, Cunico S, Prayer Galetti T, Luciani L, Fandella A, et al.
Cancer . 2005 Apr; 103(12):2507-16. PMID: 15856474
Background: The objective of the current study was to identify independent clinical and pathologic variables that were predictive of lymph node involvement in patients with squamous cell carcinoma of the...
10.
Mancini M, Cisternino A, Tavolini I, Dal Moro F, Bassi P
World J Urol . 2003 Dec; 21(6):369-76. PMID: 14689222
The potential of disease prediction in non-malignant disorders should not be undervalued. Such disorders present several characteristics which make them suitable for disease prediction: they can be wide-spread, strongly affect...